Cresco Labs (CRLBF) Cost of Revenue (2020 - 2026)

Cresco Labs has reported Cost of Revenue for 7 years, with the latest figure at $75.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 12.91% year-over-year to $75.9 million; the trailing twelve-month figure through Mar 2026 stood at $320.0 million (down 9.83% YoY), and the FY2025 full-year result was $331.3 million, down 7.95% from the prior year.
• Cost of Revenue for Q1 2026 stood at $75.9 million, down from $78.2 million in the prior quarter.
• The five-year high for Cost of Revenue was $111.9 million in Q4 2022, with the low at $75.9 million in Q1 2026.
• Historically, Cost of Revenue has averaged $94.8 million across 5 years, with a median of $92.1 million in 2024.
• Annual changes were most pronounced in 2023 — Cost of Revenue climbed 5.49% — and 2024, when it dropped 19.43%.
• Cresco Labs' Cost of Revenue stood at $111.9 million in 2022, then retreated by 17.68% to $92.1 million in 2023, then declined by 0.23% to $91.9 million in 2024, then fell by 14.86% to $78.2 million in 2025, then declined by 3.01% to $75.9 million in 2026.
• The last three Cost of Revenue figures came in at $75.9 million (Q1 2026), $78.2 million (Q4 2025), and $85.6 million (Q3 2025), per Business Quant data.